← All trials
NCT00920803
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 19, 2008
- Primary completion
- Nov 11, 2009
- Completion date
- Nov 11, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 9
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Sirtris PharmaceuticalsLead sponsor
- GlaxoSmithKlineStudy director
- GlaxoSmithKlineCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.